Profit from the miracle that’ll cure cancer and make sea water drinkable . . .

IT’S been hailed as a miracle material that could cure cancer, transform plane travel and make sea water drinkable.

Graphene, the purest form of carbon, is 200 times stronger than steel, harder than diamonds and the world’s thinnest material. On top of all that it’s also the best electrical conductor known to Man.

For years, scientists have studied its astonishing properties, many of which were revealed in the Mail last week, but big companies are only just starting to cash in. Samsung, Airbus and drug maker GlaxoSmithKline are scrambling to harness it to create futuristic new products.

From phone screens that bend to graphene- coated vehicles that appear invisible on radar and tiny implants that cure debilitating diseases, a host of innovations could change our lives.

‘Graphene is rapidly being developed by companies for all sorts of products and applications — and that could result in significant industries in the future,’ says James Baker, of the National Graphene Institute, a research division of the University of Manchester, which is working to develop the material for use in industry.

So, with the graphene revolution around the corner, how can investors turn a profit?

Electronics firm Samsung reckons graphene could solve our frustrations with smartphones.

In 2015, scientists at the Korean giant created a phone battery containing graphene that lasted nearly twice as long as current power units. While not yet used in the mobile phones we carry around today, future models might need charging only once a week, rather than once a day.

Samsung is also using graphene to develop flexible screens that bend without breaking the glass.

Chinese start-up Moxi Group last year launched a smartphone made with graphene that can be worn on the wrist like a bracelet. JP Morgan Emerging Markets, a fund recommended by broker Hargreaves Lansdown, invests £3.02 in every £100 in Samsung.

The fund, which mostly invests in Asia, has turned £10,000 into £13,300 in five years.

The aerospace industry could also benefit from graphene’s strength and remarkable ability to conduct electricity.

Airbus, the French aerospace firm, has joined forces with the National Graphene Institute to develop cutting-edge technologies to use in its planes. Graphene could be used to strengthen plane wings, which come under intense pressure during flight. And it is very light, so an aircraft made with graphene would save fuel.

Experts believe it could be an essential part of passenger planes within a decade. An unmanned prototype aircraft with graphenecovered wings made its first public flight at Farnborough Air Show last year.

For investors looking to cash in, Maike Currie, of fund broker Fidelity International, tips Invesco Perpetual Global Equity Income, which in the past five years has turned £10,000 into £19,680. Airbus is one of the fund manager Nick Mustoe’s main picks, accounting for £2.56 in every £100 of savers’ money. Ben Yearsley, of adviser Shore Financial Planning, says the JO Hambro UK Dynamic fund should also profit from the graphene revolution. The fund has returned £19,900 from £10,000 in the past five years. The fund invests £3.81 in every £ 100 in Qinetiq. The science and engineering firm set up a graphene research unit a year ago to investigate how the material can be used to make objects invisible to radar.

It’s thought graphene could be used to absorb radar waves, so they don’t bounce back to antenna.

It means military vehicles such as tanks and planes, coated in a lightweight graphene layer, would be invisible to enemy radar. Qinetiq is also looking at whether graphene could be incorporated in soldiers’ uniforms due to it being so tough and lightweight.

Another potential use is to coat wind turbines in graphene to stop them interfering with nearby airport radar stations.

One problem with the turbines is that they create a blinking dot on radar screens that can be confused for a plane.

As graphene absorbs microwaves, it’s thought it could be sprayed on to the turbines to stop the spinning blades being picked up by air traffic controllers.

Being just one atom thick and an exceptional electrical conductor, biomedical firms believe graphene could be used in tiny implants in the human body to combat chronic illnesses such as arthritis and asthma.

These implants, smaller than a grain of rice, attach themselves to nerves to regulate the electrical signals that travel between the nervous system and the organs.

GlaxoSmithKline, the British drug giant has set up a research facility with Alphabet, the parent company of Google, to research new technologies.

For investors wanting to share in its future profits, Jason Hollands, of fund broker Tilney, tips Evenlode Income, which has turned £10,000 into £20,200 in the past five years. It invests £4.70 in every £100 in GSK.